Synthesis of novel β-aminoalcohols containing nabumetone moiety with potential antidiabetic activity

Yaoxue Xuebao

Volumn 46, Issue 4, 2011, Pages 412-421

  Zhang, Kun ^a   Yan, Ju Fang ^b   Tang, Xue Mei ^a   Liu, Hong Ping ^a   Fan, Li ^a   Zhou, Guang Ming ^a   Yang, Da Cheng ^a  

^a SOUTHWEST UNIVERSITY   (China)

^b Chengdu di Ao Pharmaceutical Group Co Ltd   (China)

Author keywords

glucosidase; aminoalcohol; Diabetes mellitus; PPRE; Reduction reaction

Indexed keywords

ALPHA GLUCOSIDASE; AMINOALCOHOL; ANTIDIABETIC AGENT; BETA AMINOALCOHOL; NABUMETONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; POTASSIUM BOROHYDRIDE; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; IN VITRO STUDY; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; PROTON NUCLEAR MAGNETIC RESONANCE;

ALPHA-GLUCOSIDASES; AMINO ALCOHOLS; BUTANONES; CYCLOOXYGENASE 2 INHIBITORS; HYPOGLYCEMIC AGENTS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; RESPONSE ELEMENTS;

EID: 79958796458     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Dixit A, Saxena AK. QSAR analysis of PPAR-γ agonists as antidiabetic agents [J]. Eur J Med Chem, 2008, 43: 73-80.
2. Furukawa A, Arita T, Satoh S, et al. Discovery of a novel selective PPAR-γ modulator from Cercosporamide derivatives [J]. Bioorg Med Chem Lett, 2010, 20: 2095-2098.
3. Kaori Y, Atsuyuki H, Osamu I, et al. Flavonol caffeoylglycosides as α-glucosidase inhibitors from Spiraea cantoniensis flower [J]. J Agric Food Chem, 2008, 56: 4367-4371.
4. Matthias E, Elke L, Michael M, et al. 8-(3-(R)-Aminopiperidin-1-yl)-7- but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3, 7-dihydropurine-2, 6-dione (BI 1356), a highly potent, selective, long-acting, and orally bioavailable DPP-4 inhibitor for the treatment of type 2 diabetes [J]. J Med Chem, 2007, 50: 6450-6453.
5. Slama G, Elgrably F, Sola A, et al. Postprandial glycaemia: a plea for the frequent use of delta postprandial glycaemia in the treatment of diabetic patients [J]. Diabetes Metab, 2006, 32: 187-192.
6. Langtry HD, Balfour JA. Glimepiride. A review of its use in the management of type 2 diabetes mellitus [J]. Drugs, 1998, 55: 563-584.
7. Jorgensen MR, Alcor YB, Røst T, et al. Synthesis and analysis of novel glycerolipids for the treatment of metabolic syndrome [J]. J Med Chem, 2009, 52: 1172-1179.
8. Zbigniew K, Wieslaw M. Structural characterization of analgesic isothiazolopyridines of Mannich base type; X-ray analysis of 2-[(4-phenylpiperazin-1-yl)ethyl] and 2-[(4-methylpiperazin-1-yl)methyl]-4, 6-dimethylisothiazolo[5, 4-b]pyridin-3(2H)-ones [J]. J Mol Struct, 2008, 888: 160-167.
9. Umashankar D, Swagatika D, Brian B, et al. N-Aroyl-3, 5-bis (benzylidene)-4-piperidones: a novel class of antimycobacterial agents [J]. Bioorg Med Chem, 2008, 16: 3602-3607.
10. Alexander W, Angela C, Andreas H, et al. Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition [J]. J Med Chem, 2004, 47: 550-557.
11. Emelda AR, Jayachandramani N, Ravichandran S. Synthesis, characterization and antimicrobial study of a new Mannich base, N-(1-piperidinobenzyl)benzamide and its transition metal (II) complexes [J]. Asian J Chem, 2008, 20: 2485-2490.
12. Claudiu TS, Andrea S, Angela C. Carbonic anhydrase inhibitors [J]. Med Res Rev, 2003, 23: 146-189.
13. Zhou C, Wu G, Feng Y, et al. Discovery and biological characterization of a novel series of androgen receptor modulators [J]. Br J Pharmacol, 2008, 154: 440-450. (Pubitemid 351670592)
14. Li QL, Yang DC, Yan JF, et al. A kind of new β-amino ketone/alcohol derivatives and its use: CN, 200810148122. X. [P]. 2008-10-14.
15. Yang DC, Fan L, Liu HP, et al. A kind of new Mannich base compounds, their uses for the treatment and/or precaution against leukaemia: CN, 101381320 [P]. 2009-03-11.
16. Xu J, Yan JF, Fan L, et al. Synthesis and α-glucosidase inhibitory activity of N-(1,5-diaryl-3-pentone-1-yl)-4-aminobenzoic acid [J]. Acta Pharm Sin, 2009, 44: 48-55.
17. Song XL, Yan JF, Fan L, et al. Synthesis and preliminary evaluation of antidiabetic activity of 4-(1-aryl-3-aryl/arylalkyl-3-oxopropylamino)-N-(5- methyl-3-isoxazolyl)benzenesulfonamide [J]. Chin J Org Chem, 2009, 29: 606-613.
18. Tang XM, Yan JF, Zhang YX, et al. Synthesis and preliminary study on a-glucosidase inhibitory activity of 4-[3-(4-bromophenyl)-3-oxo-1- arylpropylamino]-N-(pyrimidin-2-yl) benzenesulfonamide [J]. Chin J Org Chem, 2009, 29: 1790-1798.
19. Zhang YX, Yan JF, Fan L, et al. Synthesis and preliminary evaluation of antidiabetic activity of 4-(3-(4-bromophenyl)-3-oxo-1-arylpropylamino)-N-(5- methylisoxazol-3-yl)benzenesulfonamide [J]. Acta Pharm Sin, 2009, 44: 1244-1251.
20. Yang DC, Yan JF, Song XL, et al. Synthesis and preliminary evaluation of antidiabetic activity of 4-[3-(4-bromophenyl)-3-oxo-1-arylpropylamino] benzenesulfonamide [J]. Acta Chim Sin, 2010, 68: 515-522.
21. Yang DC, Yan JF, Xu J, et al. Synthesis and investigation on antidiabetic activity of 4-(1-aryl-3-oxo-5-phenylpentylamino) benzenesulfonamide [J]. Acta Pharm Sin, 2010, 45: 66-71.
22. Zhou ZW, Yan JF, Tang XM, et al. Synthesis and preliminary evaluation of antidiabetic activity for β-aminoketone containing isoxazole moiety [J]. Chin J Org Chem, 2010, 30: 582-589.
23. Wen R. Organic Reactions for Drug Synthesis [M]. 2nd ed. Beijing: Chemical Industry Press, 2004: 378.
24. Krishnamurthy S, Brown HC. Selective reductions. 22. Facile reduction of α, β-unsaturated aldehydes and ketones with 9-borabicyclo [3.3.1]nonane [J]. J Org Chem, 1977, 42: 1197-1201.